Theravance Biopharma, Inc.
Theravance Biopharma is a specialty pharmaceutical company focused on respiratory and other specialty medicines with minimal direct government dependence and low political engagement.
BusinessWhat TBPH does
Theravance Biopharma develops and commercializes specialty pharmaceutical products, primarily in respiratory disease, with revenue from product sales and royalties. The company operates with a lean R&D and commercial footprint, focusing on late-stage development and commercialization of targeted therapies.
12 months past · 3 months futureTBPH activity timeline
Lifetime Government AwardsTBPH federal contracts
TBPH doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding TBPH
Politicians Trading TBPHMembers of Congress with recent TBPH positions
Congressional TradesWho in Congress is trading TBPH
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills to WatchLegislation flagged by our analysis
Political ProfileWhere TBPH sits in Washington
Theravance has minimal lobbying footprint, no campaign donations, and no legislative naming. Stock movement driven primarily by clinical trial results and FDA decisions rather than political events.
Regulatory ExposureThreats & opportunities
Regulatory threats
- FDA approval delays
- drug pricing regulation
- patent cliff exposure
Regulatory opportunities
- Orphan drug designation
- accelerated approval pathways
- patent term extension
Live signals + predictions for TBPH — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades TBPH
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord